Often disease that cause fever like Dengue, Malaria and Chickengunya have confusing symptoms and patients are put under a lot of trauma due to repetitive testing for same disease or a new test every day for a disease. This causes a lot of physical discomfort, mental trauma and most dangerously a delay in treatment. What is even more worrying is a scenario where an incorrect diagnosis may lead to life threatening situations. Hence it is important that a 100% sensitive, accurate and reliable test be conducted for diseases causing fever. In a sphere as critical as healthcare, time thus becomes of prime importance, and this is the lacunae that Metropolis Healthcare looks to fill, in its efforts to make diagnostic dilemma obsolete. The Multiplex PCR test helps diagnose seven common diseases causing fevers Malaria, Dengue, Typhoid, Leptospirosis, Chikungunya, West Nile Fever and Rickettsia. The test is seen to save cost and provide doctors to help faster diagnosis.
The Multiple PCR is done in real-time which extract nucleic acid of pathogens from whole blood. With a sensitivity and specificity of a 100 per cent , the test looks to provide a breather in terms of diagnosis to a country where according to certain estimates, 80 per cent of all illnesses are water-related.
Multiplex PCR test is expected to significantly facilitate fever screening and therefore speed up identification of patients suffering from various symptoms of infectious disease
Global & National Quality Accreditations – CAP (USA) and NABL , Govt. of India.
Guaranteed error free diagnosis.
Bar Coded and automated process. No room for manual errors.
Specific normal range for Indian population built from 33 years of experience.
Sample collection from home/office.
Metropolis: Experience + Expertise
Over the past 3 decades we have earned the respect of doctors and patients. Today we conduct over 30 million tests annually with accuracy each year. Our repertoire extends over 4500 tests and over 100 different technologies. Our customer care is available round the clock for any queries that you may have.
Save tax on the Preventive health check-ups up to Rs. 5000, under section 80D of Income Tax Act, 1961
We are Metropolis - Your Pathology Specialist
Metropolis is one of the leading diagnostics companies in India, by revenue, as of March 31, 2018 (Source: Frost & Sullivan). With operations across India, Africa, South Asia and Middle East.
Our globally accredited clinical laboratories deliver millions of accurate and timely test results every year. We offer a comprehensive range of clinical laboratory tests and profiles which are used in prediction, early detection, diagnostic screening, confirmation and monitoring of diseases.
Delivering diagnostic services since 1980
Network of 100+ clinical labs & 1100+ patient touch points
Qualified team of phlebotomists for Home collection services
Certified NABL and CAP accredited labs
Wide range of 4000+ tests & profiles
Convenience of home collection service
Metropolis Healthcare Limited is proposing subject to applicable statutory or regulatory requirements, receipt of requisite approvals, market conditions and other considerations to undertake an initial public offering of its equity shares and has filed a draft red herring prospectus dated September 27, 2018 (“DRHP”) with the Securities and Exchange Board of India (“SEBI”). The DRHP is available on the website of the SEBI at www.sebi.gov.in, BSE Limited at www.bseindia.com, National Stock Exchange of India Limited at www.nseindia.com and the websites of Book Running Lead Managers at www.jmfl.com, www.credit-suisse.com, www.investmentbank.kotak.com, www.hdfcbank.com and www.goldmansachs.com. Any potential investors should note that investment in equity shares involves a high degree of risk and for details relating to same, please refer to the DRHP including the section “Risk Factors” of the DRHP. Potential investors should not rely on the DRHP filed with the SEBI for making any investment decision.